A 2022 commentary in Wound Repair and Regeneration stated: "Fewer than 15% of compounds showing efficacy in rodent wound models achieve statistical significance in Phase III human wound trials" [8]
Most pharmacies dispense 4-week or 8-week supplies
When the FDA parked these peptides on the Category 2 do not compound list, that didn't stop people from using them, Campbell says
Allergic Reactions: Although rare, some individuals may experience allergic responses including skin rashes, hives, or in severe cases, difficulty breathing
This manifests as progressively worsening albuminuria and eGFR decline, with glomerular mesangial expansion, podocyte effacement, segmental glomerulosclerosis and tubular injury, which progress to diffuse glomerular and tubulointerstitial fibrosis [10]
November 1, 2024: FDA Issues Warning To Patients Taking Compounded Semaglutide Drugs In October, the FDA issued a letter titled, FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. In the letter, the FDA warned people taking compounded versions of GLP-1 drugs for weight loss